Log in to save to my catalogue

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone m...

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_885d126be3154d5fb0ff43b21e0f3d18

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

About this item

Full title

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

Stem cells translational medicine, 2021-09, Vol.10 (9), p.1266-1278

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Human bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM‐MSC administration in T2DM patients are contradictory. The purpose of this study was to test the hypothesis that autologous BM‐MSC administration in T2DM pati...

Alternative Titles

Full title

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_885d126be3154d5fb0ff43b21e0f3d18

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_885d126be3154d5fb0ff43b21e0f3d18

Other Identifiers

ISSN

2157-6564

E-ISSN

2157-6580

DOI

10.1002/sctm.20-0506

How to access this item